Atlas Trials

Urovant Sciences GmbH

11 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Urovant Sciences GmbH

RecordFirmDate
Open-label, Long-term Safety, Efficacy, and Pharmacokinetics Study of Vibegron in Pediatric Subjects 2 Years to < 18 Years of Age With NDO and on CIC (NCT05491525)Urovant Sciences GmbH2022-10-12
Composur: Study to Understand the Performance of Vibegron in Participants with Overactive Bladder (OAB) (NCT05067478)Urovant Sciences GmbH2021-10-28
URO-902 in Female Subjects With Overactive Bladder and Urge Urinary Incontinence (NCT04211831)Urovant Sciences GmbH2019-12-16
Extension Study of Vibegron in Men With Overactive Bladder (OAB) Symptoms on Pharmacological Therapy for Benign Prostatic Hyperplasia (NCT04103450)Urovant Sciences GmbH2019-09-19
Study to Evaluate the Efficacy, Safety and Tolerability of Vibegron in Men With Overactive Bladder (OAB) Symptoms on Pharmacological Therapy for Benign Prostatic Hyperplasia (BPH) (NCT03902080)Urovant Sciences GmbH2019-03-26
Study to Evaluate the Efficacy and Safety of Vibegron Administered Orally for 12 Weeks to Women With Irritable Bowel Syndrome (NCT03806127)Urovant Sciences GmbH2018-12-31
An Extension Study to Examine the Safety and Tolerability of a New Drug in Patients With Symptoms of Overactive Bladder (OAB). (NCT03583372)Urovant Sciences GmbH2018-06-14
A Study to Examine the Safety and Efficacy of a New Drug in Patients With Symptoms of Overactive Bladder (OAB) (NCT03492281)Urovant Sciences GmbH2018-03-26

Track Urovant Sciences GmbH automatically

Every clearance here is in the API, with alerts when new ones post.